Fulvestrant in Treating Patients With Advanced Prostate Cancer

Summary

RATIONALE: Estrogen may cause the growth of prostate cancer cells. Hormone therapy using fulvestrant may fight prostate cancer by blocking the use of estrogen by the tumor cells. PURPOSE: This phase II trial is studying how well fulvestrant works in treating patients with advanced prostate cancer.

Timeline

Start

2005-09

Primary completion

2006-10

Completion

2012-06

Drugs

Indications